| |
|
Form Serial Number: |
DA20241024E00229
|
| 1.
Date of relevant event: |
22/10/2024
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02496 |
| 4.
Name of listed corporation: |
武漢友芝友生物製藥股份有限公司 - B - H股 |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
111,468,814 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
|
| 10.
Name of director (Chinese): |
郭宏伟 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1706 | Miscellaneous
Notice filed because you ceased to be a director or chief executive of the listed corporation |
|
| 2201 | Interest of corporation controlled by you |
|
| 2201 | Interest of corporation controlled by you |
|
8,122,098 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 8,122,098 | 7.29 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 8,122,098 | 7.29 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| 共青城曜友投资中心（有限合伙） | 江西省九江市共青城市基金小镇内 | 郭宏伟 | 60.00 | N | |
| 共青城汇友兴曜二期股权投资合伙企业（有限合伙） | 江西省九江市共青城市基金小镇内 | 共青城曜友投资中心（有限合伙）（为执行事务合伙人） | 100.00 | Y | |
| 南宁曜友商务咨询合伙企业（有限合伙） | 南宁市高岭路100号行政办公楼202室 | 郭宏伟 | 60.00 | N | |
| 南宁汇友兴曜股权投资基金合伙企业（有限合伙） | 南宁市高岭路100号行政办公楼404室 | 南宁曜友商务咨询合伙企业（有限合伙）（为执行事务合伙人） | 100.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
共青城曜友投资中心（有限合伙）（「共青城曜友」）为共青城汇友兴曜二期股权投资合伙企业（有限合伙）（「共青城汇友」）的执行合伙人，郭宏伟博士为共青城曜友的最大有限合伙人，持有有限合伙权益60%。因此郭宏伟博士被视为于共青城汇友持有的1,426,827股H股中拥有权益。南宁曜友商务咨询合伙企业（有限合伙）（「南宁曜友」）为南宁汇友兴曜股权投资基金合伙企业（有限合伙）（「汇友兴曜」）的执行合伙人，郭宏伟博士为南宁曜友的最大有限合伙人，持有有限合伙权益60%。因此郭宏伟博士被视为于汇友兴曜持有的6,695,271股H股中拥有权益。
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
24/10/2024
(dd/mm/yyyy)
|
| |